Use of genetic testing to identify sudden cardiac death syndromes

Trends Cardiovasc Med. 2015 Nov;25(8):738-48. doi: 10.1016/j.tcm.2015.03.007. Epub 2015 Mar 12.


Sudden cardiac death (SCD) is a leading cause of mortality worldwide. Although coronary artery disease remains the most common substrate for SCD, primary cardiac genetic diseases, presenting with or without structural heart abnormalities, play a significant role. In the last 30 years, the study of large family pedigrees allowed the discovery of causative genes unveiling the genetic basis of diseases such as primary cardiomyopathies and arrhythmia syndromes, which are known to increase the risk of SCD. However, recent technological advancement with the ability to perform massive parallel sequencing and analyze the entire genome has uncovered a higher level of complexity in the genetic predisposition for cardiac diseases, which are usually characterized by Mendelian inheritance patterns. Clinical genetic testing, historically shaped around a monogenic Mendelian disorder paradigm, is now facing the challenge to adopt and adapt to a more complex model in which a significant portion of subjects may present with multi-allelic inheritance involving additional genes that could modulate the severity and type of disease-related phenotypes. Here, we will try to provide a viewpoint that will hopefully foster further debate in the field.

Publication types

  • Review

MeSH terms

  • Adult
  • Arrhythmogenic Right Ventricular Dysplasia / genetics
  • Arrhythmogenic Right Ventricular Dysplasia / mortality
  • Brugada Syndrome / genetics
  • Brugada Syndrome / mortality
  • Cardiomyopathy, Dilated / genetics
  • Cardiomyopathy, Dilated / mortality
  • Cardiomyopathy, Hypertrophic / genetics
  • Cardiomyopathy, Hypertrophic / mortality
  • Death, Sudden, Cardiac / epidemiology
  • Death, Sudden, Cardiac / etiology*
  • Death, Sudden, Cardiac / prevention & control
  • Female
  • Genetic Predisposition to Disease / epidemiology*
  • Genetic Testing / methods*
  • Humans
  • Long QT Syndrome / genetics
  • Long QT Syndrome / mortality
  • Male
  • Prevalence
  • Primary Prevention / methods
  • United States